Are free anti-tuberculosis drugs enough? An empirical study from three cities in China

Infectious Diseases of Poverty

Volumn 4, Issue 1, 2015, Pages

  Chen, Shanquan ^a   Zhang, Hui ^b,h   Pan, Yao ^c   Long, Qian ^d,e   Xiang, Li ^f   Yao, Lan ^f   Lucas, Henry ^g  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b National Center for TB Control and Prevention   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e DUKE KUNSHAN UNIVERSITY   (China)

^f HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^g UNIVERSITY OF SUSSEX   (United Kingdom)

^h CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Catastrophic expenditure; China; Compliance; Economic burden; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CHINA; COMPUTER ASSISTED TOMOGRAPHY; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE SURVEY; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; SPUTUM SMEAR; THORAX RADIOGRAPHY; TUBERCULOSIS; AGED; CITY; CLINICAL TRIAL; COST OF ILLNESS; DRUG COST; ECONOMICS; HEALTH SURVEY; MULTICENTER STUDY; SOCIOECONOMICS;

ADULT; AGED; ANTITUBERCULAR AGENTS; CHINA; CITIES; COST OF ILLNESS; DRUG COSTS; FEMALE; HEALTH EXPENDITURES; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PUBLIC HEALTH SURVEILLANCE; SOCIOECONOMIC FACTORS; SURVEYS AND QUESTIONNAIRES; TUBERCULOSIS;

EID: 85006189042     PISSN: 20955162     EISSN: 20499957     Source Type: Journal    
DOI: 10.1186/s40249-015-0080-y     Document Type: Article

References (58)

1. WHO. Global Tuberculosis Report 2014. Geneva: World Health Organization; 2014.
2. WHO. Introducing the WHO End TB Strategy. Geneva: World Health Organization; 2015.
3. Tadesse T, Demissie M, Berhane Y, Kebede Y, Abebe M. Long distance travelling and financial burdens discourage tuberculosis DOTs treatment initiation and compliance in Ethiopia: a qualitative study. BMC Public Health. 2013;13:424. doi: 10.1186/1471-2458-13-424.
4. van den Boogaard J, Msoka E, Homfray M, Kibiki GS, Heldens JJ, Felling AJ, et al. An exploration of patient perceptions of adherence to tuberculosis treatment in Tanzania. Qualitative Health Res. 2012;22(6):835-45. doi: 10.1177/1049732312438968.
5. Ayisi JG, van't Hoog AH, Agaya JA, McHembere W, Nyamthimba PO, Muhenje O, et al. Care seeking and attitudes towards treatment compliance by newly enrolled tuberculosis patients in the district treatment programme in rural western Kenya: a qualitative study. BMC Public Health. 2011;11:515. doi: 10.1186/1471-2458-11-515.
6. Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS medicine. 2007;4(7):e238. doi: 10.1371/journal.pmed.0040238.
7. Corbett EL, Bandason T, Cheung YB, Munyati S, Godfrey-Faussett P, Hayes R, et al. Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease. PLoS Med. 2007;4(1), e22. doi: 10.1371/journal.pmed.0040022.
8. Tang Y, Zhao M, Wang Y, Gong Y, Yin X, Zhao A, et al. Non-adherence to anti-tuberculosis treatment among internal migrants with pulmonary tuberculosis in Shenzhen. China: a cross-sectional study BMC public health. 2015;15:474. doi: 10.1186/s12889-015-1789-z.
9. Zhou C, Chu J, Liu J, Gai Tobe R, Gen H, Wang X, et al. Adherence to tuberculosis treatment among migrant pulmonary tuberculosis patients in Shandong, China: a quantitative survey study. PloS one. 2012;7(12), e52334. doi: 10.1371/journal.pone.0052334.
10. Hu D, Liu X, Chen J, Wang Y, Wang T, Zeng W, et al. Direct observation and adherence to tuberculosis treatment in Chongqing, China: a descriptive study. Health policy and planning. 2008;23(1):43-55. doi: 10.1093/heapol/czm038.
11. Yao S, Huang WH, van den Hof S, Yang SM, Wang XL, Chen W, et al. Treatment adherence among sputum smear-positive pulmonary tuberculosis patients in mountainous areas in China. BMC health services research. 2011;11:341. doi: 10.1186/1472-6963-11-341.
12. Xu W, Lu W, Zhou Y, Zhu L, Shen H, Wang J. Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study. BMC health services research. 2009;9:169. doi: 10.1186/1472-6963-9-169.
13. Driver CR, Matus SP, Bayuga S, Winters AI, Munsiff SS. Factors associated with tuberculosis treatment interruption in New York City. Journal of public health management and practice: JPHMP. 2005;11(4):361-8.
14. Zhu M, Wang J, Dib HH, Wang Z. Enhancing the management of cross-regional transfer of floating tuberculosis cases by active follow-up and communication. European journal of public health. 2012;22(4):577-82. doi: 10.1093/eurpub/ckr154.
15. Liang L, Wu Q, Gao L, Hao Y, Liu C, Xie Y, et al. Factors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from China. Thorax. 2012;67(7):632-8. doi: 10.1136/thoraxjnl-2011-200018.
16. Long Q, Smith H, Zhang T, Tang S, Garner P. Patient medical costs for tuberculosis treatment and impact on adherence in China: a systematic review. BMC public health. 2011;11:393. doi: 10.1186/1471-2458-11-393.
17. Kik SV, Olthof SP, de Vries JT, Menzies D, Kincler N, van Loenhout-Rooyakkers J, et al. Direct and indirect costs of tuberculosis among immigrant patients in the Netherlands. BMC public health. 2009;9:283. doi: 10.1186/1471-2458-9-283.
18. Liu X, Thomson R, Gong Y, Zhao F, Squire SB, Tolhurst R, et al. How affordable are tuberculosis diagnosis and treatment in rural China? An analysis from community and tuberculosis patient perspectives. Tropical medicine & international health: TM & IH. 2007;12(12):1464-71. doi: 10.1111/j.1365-3156.2007.01953.x.
19. Jackson S, Sleigh AC, Wang GJ, Liu XL. Poverty and the economic effects of TB in rural China. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease. 2006;10(10):1104-10.
20. Zhang T, Tang S, Jun G, Whitehead M. Persistent problems of access to appropriate, affordable TB services in rural China: experiences of different socio-economic groups. BMC public health. 2007;7:19. doi: 10.1186/1471-2458-7-19.
21. Xu WG, Lu W, Zhou Y, Zhu LM, Shen HB, Wang JM. Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study. BMC health services research. 2009;9. doi:Artn 169 10.1186/1472-6963-9-169.
22. Wang L, Liu J, Chin DP. Progress in tuberculosis control and the evolving public-health system in China. Lancet. 2007;369(9562):691-6. doi: 10.1016/S0140-6736(07)60316-X.
23. Wei X, Chen J, Chen P, Newell JN, Li H, Sun C, et al. Barriers to TB care for rural-to-urban migrant TB patients in Shanghai: a qualitative study. Tropical medicine & international health: TM & IH. 2009;14(7):754-60. doi: 10.1111/j.1365-3156.2009.02286.x.
24. Pan HQ, Bele S, Feng Y, Qiu SS, Lu JQ, Tang SW, et al. Analysis of the economic burden of diagnosis and treatment of tuberculosis patients in rural China. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease. 2013;17(12):1575-80. doi: 10.5588/ijtld.13.0144.
25. Liu Q, Smith H, Wang Y, Tang S, Wang Q, Garner P. Tuberculosis patient expenditure on drugs and tests in subsidised, public services in China: a descriptive study. Tropical medicine & international health: TM & IH. 2010;15(1):26-32. doi: 10.1111/j.1365-3156.2009.02427.x.
26. Wei X, Zou G, Walley J, Yin J, Lonnroth K, Uplekar M, et al. China tuberculosis policy at crucial crossroads: comparing the practice of different hospital and tuberculosis control collaboration models using survey data. PloS one. 2014;9(3), e90596. doi: 10.1371/journal.pone.0090596.
27. Liu M, Zhang Q, Lu M, Kwon CS, Quan H. Rural and urban disparity in health services utilization in China. Medical care. 2007;45(8):767-74. doi: 10.1097/MLR.0b013e3180618b9a.
28. Mauch V, Bonsu F, Gyapong M, Awini E, Suarez P, Marcelino B, et al. Free tuberculosis diagnosis and treatment are not enough: patient cost evidence from three continents. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease. 2013;17(3):381-7. doi: 10.5588/ijtld.12.0368.
29. Umar NA, Fordham R, Abubakar I, Bachmann M. The indirect cost due to pulmonary Tuberculosis in patients receiving treatment in Bauchi State-Nigeria. Cost effectiveness and resource allocation: C/E. 2012;10(1):6. doi: 10.1186/1478-7547-10-6.
30. WHO. Addressing poverty in TB control. Options for National TB Control Programmes. 2005th ed. Geneva: World Health Organization; 2005.
31. Wei X, Zou G, Yin J, Walley J, Zhang X, Li R, et al. Effective reimbursement rates of the rural health insurance among uncomplicated tuberculosis patients in China. Tropical medicine & international health: TM & IH. 2015;20(3):304-11. doi: 10.1111/tmi.12438.
32. Qiu S, Pan H, Zhang S, Peng X, Zheng X, Xu G, et al. Is tuberculosis treatment really free in China? A study comparing two areas with different management models. PloS one. 2015;10(5):e0126770. doi: 10.1371/journal.pone.0126770.
33. Zhan S, Wang L, Yin A, Blas E. Revenue-driven in TB control--three cases in China. Int J Health Plann Manag. 2004;19 Suppl 1:S63-78. doi: 10.1002/hpm.778.
34. Qing-ping S, Xiao-dong J, Feng D, Yan L, Mei-ling Y, Jin-xiu Z, et al. Consequences, measurement, and evaluation of the costs associated with adverse drug reactions among hospitalized patients in China. BMC Health Serv Res. 2014;14:73. doi: 10.1186/1472-6963-14-73.
35. Chiatti C, Bustacchini S, Furneri G, Mantovani L, Cristiani M, Misuraca C, et al. The economic burden of inappropriate drug prescribing, lack of adherence and compliance, adverse drug events in older people: a systematic review. Drug Saf. 2012;35 Suppl 1:73-87. doi: 10.1007/bf03319105.
36. Jang D, Mattila AS, Bai B. Restaurant membership fee and customer choice: The effects of sunk cost and feelings of regret. Int J Hosp Manag. 2007;26(3):687-97.
37. McElhinney D, Proctor T. Concept of entrapment and decision-making. Manag Decis. 2005;2(43):189-202.
38. Christensen-Szalanski JJ, Northcraft GB. Patient compliance behavior: the effects of time on patients' values of treatment regimens. Soc Sci Medicine. 1985;21(3):263-73.
39. Grellety E, Luquero FJ, Mambula C, Adamu HH, Elder G, Porten K. Observational bias during nutrition surveillance: results of a mixed longitudinal and cross-sectional data collection system in Northern Nigeria. PloS One. 2013;8(5), e62767. doi: 10.1371/journal.pone.0062767.
40. Auld AF, Mbofana F, Shiraishi RW, Alfredo C, Sanchez M, Ellerbrock TV, et al. Incidence and determinants of tuberculosis among adults initiating antiretroviral therapy--Mozambique, 2004-2008. PloS One. 2013;8(1):e54665. doi: 10.1371/journal.pone.0054665.
41. Loyalka P, Liu L, Chen G, Zheng X. The cost of disability in china. Demography. 2014;51(1):97-118. doi: 10.1007/s13524-013-0272-7.
42. Wang H, Ye F, Wang Y, Huntington D. Economic impact of maternal death on households in rural china: a prospective cohort study. PloS One. 2013;8(10):e76624. doi: 10.1371/journal.pone.0076624.
43. Meng Q, Xu L, Zhang Y, Qian J, Cai M, Xin Y, et al. Trends in access to health services and financial protection in China between 2003 and 2011: a cross-sectional study. Lancet. 2012;379(9818):805-14. doi: 10.1016/s0140-6736(12)60278-5.
44. Li Y, Wu Q, Xu L, Legge D, Hao Y, Gao L, et al. Factors affecting catastrophic health expenditure and impoverishment from medical expenses in China: policy implications of universal health insurance. Bull World Health Organ. 2012;90(9):664-71. doi: 10.2471/BLT.12.102178.
45. Shi W, Chongsuvivatwong V, Geater A, Zhang J, Zhang H, Brombal D. Effect of household and village characteristics on financial catastrophe and impoverishment due to health care spending in Western and Central Rural China: A multilevel analysis. Health Res Policy Syst. 2011;9:16. doi: 10.1186/1478-4505-9-16.
46. Aspler A, Menzies D, Oxlade O, Banda J, Mwenge L, Godfrey-Faussett P, et al. Cost of tuberculosis diagnosis and treatment from the patient perspective in Lusaka. Zambia Int J Tuberc Lung Dis. 2008;12(8):928-35.
47. Waters HR, Anderson GF, Mays J. Measuring financial protection in health in the United States. Health policy. 2004;69(3):339-49. doi: 10.1016/j.healthpol.2004.01.003.
48. Ranson MK. Reduction of catastrophic health care expenditures by a community-based health insurance scheme in Gujarat, India: current experiences and challenges. Bull World Health Organ. 2002;80(8):613-21.
49. Becerra MC, Appleton SC, Franke MF, Chalco K, Arteaga F, Bayona J, et al. Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study. Lancet. 2011;377(9760):147-52. doi: 10.1016/S0140-6736(10)61972-1.
50. Smith J, Firth J. Qualitative data analysis: the framework approach. Nurse Res. 2011;18(2):52-62. doi: 10.7748/nr2011.01.18.2.52.c8284.
51. Liu Q, Smith H, Wang Y, Tang SL, Wang QL, Garner P. Tuberculosis patient expenditure on drugs and tests in subsidised, public services in China: a descriptive study. Trop Med Int Health. 2010;15(1):26-32. doi: 10.1111/j.1365-3156.2009.02427.x.
52. Liu Q, Garner P, Wang Y, Huang B, Smith H. Drugs and herbs given to prevent hepatotoxicity of tuberculosis therapy: systematic review of ingredients and evaluation studies. BMC Public Health. 2008;8:365. doi: 10.1186/1471-2458-8-365.
53. Babiarz KS, Miller G, Yi H, Zhang L, Rozelle S. New evidence on the impact of China's New Rural Cooperative Medical Scheme and its implications for rural primary healthcare: multivariate difference-in-difference analysis. BMJ. 2010;341:c5617. doi: 10.1136/bmj.c5617.
54. Meng Q, Xu K. Progress and challenges of the rural cooperative medical scheme in China. Bull World Health Organ. 2014;92(6):447-51. doi: 10.2471/BLT.13.131532.
55. Rouzier VA, Oxlade O, Verduga R, Gresely L, Menzies D. Patient and family costs associated with tuberculosis, including multidrug-resistant tuberculosis, in Ecuador. Int J Tuberc Lung Dis. 2010;14(10):1316-22.
56. Tola HH, Tol A, Shojaeizadeh D, Garmaroudi G. Tuberculosis Treatment Non-Adherence and Lost to Follow Up among TB Patients with or without HIV in Developing Countries: A Systematic Review. Iran J Public Health. 2015;44(1):1-11.
57. Nglazi MD, Bekker LG, Wood R, Hussey GD, Wiysonge CS. Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review. BMC Infect Dis. 2013;13:566. doi: 10.1186/1471-2334-13-566.
58. Kunawararak P, Pongpanich S, Chantawong S, Pokaew P, Traisathit P, Srithanaviboonchai K, et al. Tuberculosis treatment with mobile-phone medication reminders in northern Thailand. Southeast Asian J Trop Med Public Health. 2011;42(6):1444-51.